2027 ICD-10-CM Diagnosis Code Z15.81Genetic susceptibility to multiple endocrine neoplasia [MEN]
Z15.81 is a billable ICD-10-CM diagnosis code for genetic susceptibility to multiple endocrine neoplasia [MEN]. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 951. The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. Coders also document this condition as genetic predisposition. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Genetic susceptibility to disease.
Code Identity
Code Classification
Code EditsBilling
Medicare Code Editor checks that affect claim validity for Z15.81.
Present on Admission (POA)Billing
Z15.81 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review the other POA exempt codes in Genetic carrier and genetic susceptibility to disease (Z14-Z15).
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Genetic predisposition
- Genetic predisposition to multiple endocrine adenomatosis
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to Z15.81: its own notes plus those printed at Z15 and Chapter 21. A note printed at a category, block or chapter applies to every code under it.
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
- multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Use Additional Code
Add a second code, after this one, to fully describe the condition.
Notes
General instructions on how these codes are used.
- Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
- (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
- (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name Z15.81, its category, or a range that includes it.
Use Additional Code 1
These codes say to use an additional code from the note, and Z15.81 is one of the codes named.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Multiple endocrine neoplasia
Multiple endocrine neoplasia is a group of disorders that affect the body's network of hormone-producing glands called the endocrine system. Hormones are chemical messengers that travel through the bloodstream and regulate the function of cells and tissues throughout the body.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert Z15.81 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About Z15.81Overview
What is the ICD-10 code for genetic susceptibility to multiple endocrine neoplasia [MEN]?
The ICD-10-CM code for genetic susceptibility to multiple endocrine neoplasia [MEN] is Z15.81 (sometimes written as Z1581). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is Z15.81 (Genetic susceptibility to other disease) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report genetic susceptibility to multiple endocrine neoplasia [MEN] on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does Z15.81 group to?
On inpatient claims, genetic susceptibility to multiple endocrine neoplasia [MEN] maps to MS-DRG 951 (other Factors Influencing Health Status), which carries a relative weight of 0.5574. Higher weights mean higher Medicare reimbursement.
Can Z15.81 be a principal diagnosis?
No. The Medicare Code Editor rejects this code as a principal diagnosis because genetic susceptibility to multiple endocrine neoplasia [MEN] describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.
Is Z15.81 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for genetic susceptibility to multiple endocrine neoplasia [MEN] on inpatient claims. The code appears in the Genetic carrier and genetic susceptibility to disease (Z14-Z15) range of the CMS exempt list.